ARISING HEALTHALIVE. AWAKE. AWARE.Read the magazines →

← November 14, 2026 edited reader edition

THE ARISING · Longevity & Healthspan

Some epigenetic clocks responded to interventions. That is not proof of slower aging.

November 14, 2026 · Longevity & Healthspan

An epigenetic clock turns a pattern of chemical marks on DNA into a score. If that score changes after a treatment, does it mean the treatment will help people stay healthy longer? A Nature Medicine analysis tackles the first part of the question: how often and how consistently the scores respond.

The authors assembled data from 51 human intervention studies and applied 16 established epigenetic clocks. In the compiled data, drug and lifestyle interventions lowered estimated epigenetic age when analyzed as categories. Supplements did not show a clear reduction as a group. That does not rule out effects from any individual supplement, or establish that a particular drug slows aging.

The clocks themselves responded differently. Those designed to estimate mortality risk or the pace of aging tended to respond more strongly, while the study population and length of follow-up also mattered. The team compared categories drawn from different studies, not treatments assigned head to head in a single large trial.

The practical question for researchers is whether a responsive score can reliably predict what happens to people after treatment. This study did not establish that clock changes translate into longer life, less disease, or better function. A test can register a change without establishing that the change improves health.

The paper was published online August 21, 2026, and is revisited in this November issue.

Primary source: Sehgal and colleagues, *Nature Medicine*

THE ARISING NEWSLETTER

Science moves forward.
Come with it.

Research, clear explanations, and a little room for wonder.
Read and follow The Arising on Substack.

Find The Arising on Substack ↗